Cytogenetic and Molecular Failure at 12 Months will be the Optimal Time Point for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis in Patients with Chronic Myeloid Leukemia: The Analysis Based on 2013 European LeukemiaNet Recommendation
Titel:
Cytogenetic and Molecular Failure at 12 Months will be the Optimal Time Point for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis in Patients with Chronic Myeloid Leukemia: The Analysis Based on 2013 European LeukemiaNet Recommendation
Auteur:
Kim, Hee-Je Yoo, Hea-Lyun Lee, Won-Sik Kim, Hyeong-Joon Kong, Jee Hyun Choi, Yunsuk Do, Young Rok Kwak, Jae-Yong Oh, Sukjoong Kim, Sung Hyun Kim, Jeong-A. Zang, Dae Young Mun, Yeung-Chul Won, Young-Woong Lee, Sung-Eun Kim, Dong-Wook